GUIDED THERAPEUTICS INC (OTCMKTS:GTHP) Sellers Increased By 465100% Their Shorts As Of Feb 14, 2019

Change of 465100% for GUIDED THERAPEUTICS INC (OTCMKTS:GTHP)’s shares shorted was showed. It was issued in February by FINRA the 465,200 shares shorted on GTHP. The 100 previous shares are up with 465100%.

Lastly it traded at $0.0003.Since February 14, 2018 it’s 0.00% down thus . GTHP by 0.00% the S&P500.

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices.The company has $795,681 market cap. The firm focuses on marketing LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.Last it reported negative earnings. It is also developing a non-invasive esophageal cancer detection product using its biophotonic technology platform.

A couple more Guided Therapeutics, Inc. (OTCMKTS:GTHP) news were released by: Prnewswire.com which released on December 06, 2018 “OTC Markets Group Announces Lists of Compliance Downgrades and Caveat Emptor Designations for the Month of November – PRNewswire”, also Seekingalpha.com on January 15, 2017 released “Guided Therapeutics Seeks $5 Million New Financing – Seeking Alpha”, the next Seekingalpha.com is “Guided Therapeutics announces new agreement to promote sales and marketing in Russia and Eastern Europe – Seeking Alpha” on September 21, 2018. Seekingalpha.com has article titled “Terra Tech: Complete Smokeshow – Questionable Management, Poorly Run Business, And Dilution Risk – Seeking Alpha”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.